Literature DB >> 3028709

Characterization of a specific antiserum to rabbit stromelysin and demonstration of the synthesis of collagenase and stromelysin by stimulated rabbit articular chondrocytes.

G Murphy, R M Hembry, J J Reynolds.   

Abstract

An antiserum to rabbit bone stromelysin (proteoglycanase) was raised in sheep and characterized as specific, recognizing the enzyme from both different tissue sources and different species. This antiserum and a specific antiserum to rabbit bone collagenase were used in the study of metalloproteinase production by rabbit articular chondrocytes stimulated with either interleukin 1 or mononuclear cell-conditioned medium. It was shown by electroimmunoblotting that the apparently co-ordinate (mole:mole) induction of collagenase and stromelysin activity with time correlated in either case with an increase in enzyme protein. The stimulated production of both enzymes could be modified in parallel by a variety of compounds. Immunohistochemical studies confirmed that although most cells were producing both metalloproteinases simultaneously, some chondrocytes produced detectable levels of only one. The data are discussed in relation to the mechanisms of breakdown in connective tissues.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3028709     DOI: 10.1016/s0174-173x(86)80005-x

Source DB:  PubMed          Journal:  Coll Relat Res        ISSN: 0174-173X


  31 in total

1.  Cell-mediated degradation of type IV collagen and gelatin films is dependent on the activation of matrix metalloproteinases.

Authors:  S J Atkinson; R V Ward; J J Reynolds; G Murphy
Journal:  Biochem J       Date:  1992-12-01       Impact factor: 3.857

2.  Proteolytic mechanisms of cartilage breakdown: a target for arthritis therapy?

Authors:  D J Buttle; H Bramwell; A P Hollander
Journal:  Clin Mol Pathol       Date:  1995-08

3.  Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization.

Authors:  A M Henney; P R Wakeley; M J Davies; K Foster; R Hembry; G Murphy; S Humphries
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-15       Impact factor: 11.205

4.  The presence and possible functions of the matrix metalloproteinase collagenase activator protein in developing enamel matrix.

Authors:  P K DenBesten; L M Heffernan; B V Treadwell; B J Awbrey
Journal:  Biochem J       Date:  1989-12-15       Impact factor: 3.857

5.  Stromelysin is an activator of procollagenase. A study with natural and recombinant enzymes.

Authors:  G Murphy; M I Cockett; P E Stephens; B J Smith; A J Docherty
Journal:  Biochem J       Date:  1987-11-15       Impact factor: 3.857

6.  Chondrocyte activation by interleukin-1: synergism with fibroblast growth factor and phorbol myristate acetate.

Authors:  G Bandara; C W Lin; H I Georgescu; D Mendelow; C H Evans
Journal:  Agents Actions       Date:  1989-06

7.  Human recombinant interleukin-1 regulates cellular mRNA levels of dermatan sulphate proteoglycan core protein.

Authors:  J Heino; V M Kähäri; A Mauviel; T Krusius
Journal:  Biochem J       Date:  1988-05-15       Impact factor: 3.857

8.  Recombinant human interleukin-1 alpha and recombinant human interleukin-1 beta stimulate cartilage matrix degradation and inhibit glycosaminoglycan synthesis.

Authors:  R J Smith; N A Rohloff; L M Sam; J M Justen; M R Deibel; J C Cornette
Journal:  Inflammation       Date:  1989-08       Impact factor: 4.092

9.  Expression of 92-kD type IV collagenase/gelatinase (gelatinase B) in osteoarthritic cartilage and its induction in normal human articular cartilage by interleukin 1.

Authors:  M Mohtai; R L Smith; D J Schurman; Y Tsuji; F M Torti; N I Hutchinson; W G Stetler-Stevenson; G I Goldberg
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

10.  Fibroblast and neutrophil collagenases cleave at two sites in the cartilage aggrecan interglobular domain.

Authors:  A J Fosang; K Last; V Knäuper; P J Neame; G Murphy; T E Hardingham; H Tschesche; J A Hamilton
Journal:  Biochem J       Date:  1993-10-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.